$5.910
-0.030 (-0.51%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de EBS por análisis de gráficos similares
Alphio's EBS stock price prediction model matches the current Emergent BioSolutions Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $5.95 (+0.61%). The 1-week path is $5.87 (-0.74%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Emergent BioSolutions Inc?
Emergent BioSolutions Inc (EBS) is not a good buy right now due to a significant net loss of $180.2 million reported in Q2 2026, alongside a current price of $5.91 that is well below its 200-day moving average of $9.14. Additionally, the RSI is at 72.702, indicating the stock is overbought, and insider selling has increased by 140.86%, suggesting a lack of confidence from those within the company. The main risk is the company's ongoing transition phase and competition in the naloxone market, which has led to lowered earnings expectations and price target cuts from analysts.
EBS cerró en $5.91 el Friday, tras bajar -0.51%
Emergent BioSolutions Inc (EBS) last closed at $5.91, losing -0.51%. These facts feed the 1-day and 1-week EBS price prediction above.
Consenso de analistas
Emergent BioSolutions Inc (EBS): 5 comprar, 1 mantener, 0 vender. Perspectiva: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Factores de la previsión
Los factores de la previsión de Emergent BioSolutions Inc (EBS) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de EBS, ordenadas por similitud.
Análisis de estacionalidad de EBS
Historically the probability of a positive August return for EBS is 34.92%. December offers the highest probability of a positive month at 100.00%, while April is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de EBS
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Aug 2026 | $3.45 | $5.34 | $7.51 | -9.56% |
| Sep 2026 | $5.05 | $6.25 | $6.27 | +5.83% |
| Oct 2026 | $6.63 | $7.63 | $9.10 | +29.14% |
| Nov 2026 | $4.09 | $6.02 | $8.10 | +1.82% |
| Dec 2026 | $4.14 | $6.42 | $7.49 | +8.67% |
En 2026, se proyecta que Emergent BioSolutions Inc (EBS) oscile entre $3.45 y $9.10.
Previsión mensual de Emergent BioSolutions Inc para 2026
En Aug de 2026, se proyecta que Emergent BioSolutions Inc promedie $5.34, con un mínimo de $3.45 y un máximo de $7.51.
En Sep de 2026, se proyecta que Emergent BioSolutions Inc promedie $6.25, con un mínimo de $5.05 y un máximo de $6.27.
En Oct de 2026, se proyecta que Emergent BioSolutions Inc promedie $7.63, con un mínimo de $6.63 y un máximo de $9.10.
En Nov de 2026, se proyecta que Emergent BioSolutions Inc promedie $6.02, con un mínimo de $4.09 y un máximo de $8.10.
En Dec de 2026, se proyecta que Emergent BioSolutions Inc promedie $6.42, con un mínimo de $4.14 y un máximo de $7.49.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.